SuperGen, Inc. to Release 2007 First Quarter Financial Results May 2
DUBLIN, Calif., April 27 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that it will release its 2007 first quarter financial results at 4 p.m. EDT on Wednesday, May 2, 2007.
The company will host a conference call with the financial community to discuss the results for the three months ended March 31, 2007, and any revised outlook for the future. A live Webcast of the conference call will begin at 4:30 p.m. EDT that day.
The call will be Webcast by CCBN and can be accessed in the Investor Relations section of SuperGen's Web site at www.supergen.com. A replay will be available in the same location for 90 days following the call.
The Webcast will also be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the Webcast through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the Webcast via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase inhibitors and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen Noonan Russo Timothy L. Enns Greg Geissman S.V.P., Corporate Communications Director of Media Relations & Business Development (925) 560-0100 x111 (619) 814-3510 email@example.com@eurorscg.comSuperGen
CONTACT: Timothy L. Enns, S.V.P., Corporate Communications& BusinessDevelopment, SuperGen, +1-925-560-0100 x111, firstname.lastname@example.org; or GregGeissman, Director of Media Relations, +1-619-814-3510,email@example.com, for SuperGen
Web site: http://www.supergen.com/